MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression
Gabriela Sarti Kinker, Luiza H. Ostrowski, P. A. C. Ribeiro, Rony Chanoch, Sandra Márcia Muxel, Itay Tirosh, Gilberto Spadoni, Silvia Rivara, Vilma R. Martins, Tiago G. Santos, Regina P. Markus, Pedro Augusto Carlos Magno Fernandes
Topics & Concepts
GliomaMelatoninCancer researchCell cycleCancerBrain tumorBiologyReceptorTumor progressionCancer cellInternal medicineMedicineEndocrinologyPathologyCircadian rhythm and melatoninEpigenetics and DNA MethylationMicrotubule and mitosis dynamics